|
Volumn 56, Issue 3, 2005, Pages 252-258
|
Assessment of VEGF and VEGF receptor concentrations in patients with benign and malignant thyroid tumors;Ocena stezeń naczyniowo-śródbłonkowego czynnika wzrostu (VEGF) oraz jego rozpuszczalnych receptorów (sVEGFR-1,sVEGFR-2) w surowicy krwi u chorych z łagodnymi i złośliwymi guzami tarczycy.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
TUMOR MARKER;
VASCULOTROPIN A;
VASCULOTROPIN RECEPTOR;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
BIOPSY;
BLOOD;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIFFERENTIAL DIAGNOSIS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
THYROID TUMOR;
ADENOCARCINOMA, FOLLICULAR;
ADULT;
AGED;
BIOPSY;
DIAGNOSIS, DIFFERENTIAL;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
THYROID NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 33644978578
PISSN: 0423104X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|